Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02108028 · ClinicalTrials.gov registry record

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
272
Enrollment target

NCT02108028: Completed study, sponsored by National Cancer Institute (NCI).

NCT02108028 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 272 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02108028 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
272 participants
Enrollment target

Study Summary

Background: \- There are very few documents to help young adults living with advanced cancer discuss their concerns and end-of-life preferences. A new document, Voicing My CHOiCES, allows young adults to explain what kind of care they would want if they became unable to communicate or make medical decisions on their own. Researchers want to study if this document is helpful. Objective: \- To study if Voicing My CHOiCES(TM) can reduce anxiety, improve sense of support, and improve communication about advanced care planning. Eligibility: \- Adults 18 to 39 years old being treated for cancer. Design: * Participants will answer questions about their age, sex, employment, religion, health, and marital status. They will also complete several brief questionnaires: 1. General Anxiety Short Form 2. Peace, Equanimity and Acceptance in the Cancer Experience 3. Functional Assessment of Social Support 4. Quality of Communication 5. Prior Communication about Advanced Care Planning * Then a health care professional will introduce Voicing My CHOiCES . Participants will review the document and comment on parts they find relevant. They will also say if any important items are missing. Participants will complete 3 pages of the document with the assistance of a health care provider. They will be asked for positive and negative observations. * The second stage of the study will take place about 1 month later. Participants will repeat the brief questionnaires listed above. They will be asked if they shared any of the preferences they described when completing the 3 pages of Voicing My CHOiCES during visit 1 with a family member, friend, or health care provider. Research staff will ask the participant for permission to contact the people they spoke with in order to learn whether their conversations about the document were helpful. They will ask for feedback on how to make Voicing My CHOiCES more helpful.

Trial Details

FieldValue
Enrollment Target 272 participants
Start Date 2014-04-03
Est. Completion 2024-07-24

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT02108028

The ClinicalTrials.gov registry entry for NCT02108028 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02108028 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02108028 about?

NCT02108028 is a clinical study titled "Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer". Background: \- There are very few documents to help young adults living with advanced cancer discuss their concerns and end-of-life preferences. A new document, Voicing My CHOiCES, allows young adults to explain what kind of care they would want if they became unable to communicate or make medical ...

What is the current status of trial NCT02108028?

This trial is currently completed. The enrollment target is 272 participants. The study started on 2014-04-03. Estimated completion is 2024-07-24.

Who is sponsoring clinical trial NCT02108028?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.